世界の乳がん診断・薬物技術市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Breast Cancer Diagnostic and Drug Technologies Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12116 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、乳がん診断・薬物技術のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。乳がん診断・薬物技術の種類別市場規模（マンモグラフィ、生検、その他）、用途別市場規模（乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・乳がん診断・薬物技術の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Roche、BioMerieux、Becton Dickinson、GE Healthcare、Hologic、Philips、PerkinElmer、Quest Diagnostics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：マンモグラフィ、生検、その他 ・用途別分析2016年-2026年：乳管癌、浸潤性乳管癌、小葉癌、トリプルネガティブ乳がん ・乳がん診断・薬物技術の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・乳がん診断・薬物技術のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・乳がん診断・薬物技術のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・乳がん診断・薬物技術の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・乳がん診断・薬物技術の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Breast Cancer Diagnostic and Drug Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Breast Cancer Diagnostic and Drug Technologies size is estimated to be USD 17820 million in 2026 from USD 16520 million in 2020, with a change XX% between 2020 and 2021. The global Breast Cancer Diagnostic and Drug Technologies market size is expected to grow at a CAGR of 1.9% for the next five years.

Market segmentation
Breast Cancer Diagnostic and Drug Technologies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Mammography
Biopsy
Other

Market segment by Application, can be divided into
Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer

Market segment by players, this report covers
Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Breast Cancer Diagnostic and Drug Technologies
1.2 Classification of Breast Cancer Diagnostic and Drug Technologies by Type
1.2.1 Overview: Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type in 2020
1.2.3 Mammography
1.2.4 Biopsy
1.2.5 Other
1.3 Global Breast Cancer Diagnostic and Drug Technologies Market by Application
1.3.1 Overview: Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Ductal Carcinoma of Breast
1.3.3 Invasive Ductal Carcinoma
1.3.4 Lobular Carcinoma
1.3.5 Triple Negative Breast Cancer
1.4 Global Breast Cancer Diagnostic and Drug Technologies Market Size & Forecast
1.5 Global Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast by Region
1.5.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region, (2016-2021)
1.5.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size and Prospect (2016-2026)
1.5.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size and Prospect (2016-2026)
1.5.6 South America Breast Cancer Diagnostic and Drug Technologies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Breast Cancer Diagnostic and Drug Technologies Market Drivers
1.6.2 Breast Cancer Diagnostic and Drug Technologies Market Restraints
1.6.3 Breast Cancer Diagnostic and Drug Technologies Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.1.4 Abbott Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.2.4 Roche Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 BioMerieux
2.3.1 BioMerieux Details
2.3.2 BioMerieux Major Business
2.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.3.4 BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 BioMerieux Recent Developments and Future Plans
2.4 Becton Dickinson
2.4.1 Becton Dickinson Details
2.4.2 Becton Dickinson Major Business
2.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.4.4 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Becton Dickinson Recent Developments and Future Plans
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.5.4 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GE Healthcare Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.6.4 Hologic Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Philips
2.7.1 Philips Details
2.7.2 Philips Major Business
2.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.7.4 Philips Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Philips Recent Developments and Future Plans
2.8 PerkinElmer
2.8.1 PerkinElmer Details
2.8.2 PerkinElmer Major Business
2.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.8.4 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 PerkinElmer Recent Developments and Future Plans
2.9 Quest Diagnostics
2.9.1 Quest Diagnostics Details
2.9.2 Quest Diagnostics Major Business
2.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product and Solutions
2.9.4 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Quest Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Breast Cancer Diagnostic and Drug Technologies Players Market Share
3.2.2 Top 10 Breast Cancer Diagnostic and Drug Technologies Players Market Share
3.2.3 Market Competition Trend
3.3 Breast Cancer Diagnostic and Drug Technologies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue and Market Share by Type (2016-2021)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application (2016-2021)
5.2 Breast Cancer Diagnostic and Drug Technologies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2026)
6.2 North America Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2026)
6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country
6.3.1 North America Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2026)
6.3.2 United States Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
6.3.3 Canada Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
6.3.4 Mexico Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2026)
7.2 Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2026)
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country
7.3.1 Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2026)
7.3.2 Germany Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
7.3.3 France Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
7.3.5 Russia Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
7.3.6 Italy Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2026)
8.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2026)
8.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region
8.3.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Region (2016-2026)
8.3.2 China Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
8.3.3 Japan Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
8.3.4 South Korea Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
8.3.5 India Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
8.3.7 Australia Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2026)
9.2 South America Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2026)
9.3 South America Breast Cancer Diagnostic and Drug Technologies Market Size by Country
9.3.1 South America Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2026)
9.3.2 Brazil Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
9.3.3 Argentina Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2026)
10.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2026)
10.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country
10.3.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2026)
10.3.2 Turkey Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
10.3.4 UAE Breast Cancer Diagnostic and Drug Technologies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 9. Abbott Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 13. Roche Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 15. BioMerieux Major Business
Table 16. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 17. BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 19. Becton Dickinson Major Business
Table 20. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 21. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 23. GE Healthcare Major Business
Table 24. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 25. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Hologic Corporate Information, Head Office, and Major Competitors
Table 27. Hologic Major Business
Table 28. Hologic Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 29. Hologic Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Philips Corporate Information, Head Office, and Major Competitors
Table 31. Philips Major Business
Table 32. Philips Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 33. Philips Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 35. PerkinElmer Major Business
Table 36. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 37. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. Quest Diagnostics Major Business
Table 40. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product and Solutions
Table 41. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) by Players (2019-2021)
Table 43. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players (2019-2021)
Table 44. Breakdown of Breast Cancer Diagnostic and Drug Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Breast Cancer Diagnostic and Drug Technologies Players Head Office, Products and Services Provided
Table 46. Breast Cancer Diagnostic and Drug Technologies Mergers & Acquisitions in the Past Five Years
Table 47. Breast Cancer Diagnostic and Drug Technologies New Entrants and Expansion Plans
Table 48. Global Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) by Type (2016-2021)
Table 49. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Type (2016-2021)
Table 50. Global Breast Cancer Diagnostic and Drug Technologies Revenue Forecast by Type (2021-2026)
Table 51. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2021)
Table 52. Global Breast Cancer Diagnostic and Drug Technologies Revenue Forecast by Application (2021-2026)
Table 53. North America Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Breast Cancer Diagnostic and Drug Technologies Picture
Figure 2. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type in 2020
Figure 3. Mammography
Figure 4. Biopsy
Figure 5. Other
Figure 6. Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application in 2020
Figure 7. Ductal Carcinoma of Breast Picture
Figure 8. Invasive Ductal Carcinoma Picture
Figure 9. Lobular Carcinoma Picture
Figure 10. Triple Negative Breast Cancer Picture
Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Breast Cancer Diagnostic and Drug Technologies Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Region (2016-2026)
Figure 14. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Region in 2020
Figure 15. North America Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Breast Cancer Diagnostic and Drug Technologies Market Drivers
Figure 21. Breast Cancer Diagnostic and Drug Technologies Market Restraints
Figure 22. Breast Cancer Diagnostic and Drug Technologies Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. Roche Recent Developments and Future Plans
Figure 25. BioMerieux Recent Developments and Future Plans
Figure 26. Becton Dickinson Recent Developments and Future Plans
Figure 27. GE Healthcare Recent Developments and Future Plans
Figure 28. Hologic Recent Developments and Future Plans
Figure 29. Philips Recent Developments and Future Plans
Figure 30. PerkinElmer Recent Developments and Future Plans
Figure 31. Quest Diagnostics Recent Developments and Future Plans
Figure 32. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players in 2020
Figure 33. Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Breast Cancer Diagnostic and Drug Technologies Revenue Market Share in 2020
Figure 35. Global Top 10 Players Breast Cancer Diagnostic and Drug Technologies Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Type in 2020
Figure 38. Global Breast Cancer Diagnostic and Drug Technologies Market Share Forecast by Type (2021-2026)
Figure 39. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application in 2020
Figure 40. Global Breast Cancer Diagnostic and Drug Technologies Market Share Forecast by Application (2021-2026)
Figure 41. North America Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Type (2016-2026)
Figure 42. North America Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Application (2016-2026)
Figure 43. North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Country (2016-2026)
Figure 44. United States Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Type (2016-2026)
Figure 48. Europe Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Application (2016-2026)
Figure 49. Europe Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Country (2016-2026)
Figure 50. Germany Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Region (2016-2026)
Figure 58. China Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Type (2016-2026)
Figure 65. South America Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Application (2016-2026)
Figure 66. South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---